Concepedia

Michel Burcklen

MB

3

Publications

365

Citations

3

H-Index

2014

Active since

Affiliations

Charles University(Current)

Ottawa Hospital Research Institute

Sapienza University of Rome

University of Ottawa

Ottawa Hospital

Michel Burcklen is an author at Charles University specializing in dermatology, clinical trials, and medicine.

ORCID

Top concepts

Publications per year

2014–2022

3

Publications

3

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study

Ludwig Kappos, Robert J. Fox, Michel Burcklen et al. · JAMA Neurology · 2021 · 203 citations · Full text

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

Andrea Vaclavkova, Sergio Chimenti, Petr Arenberger et al. · The Lancet · 2014 · 144 citations

, , +5

Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis

Mark S. Freedman, Carlo Pozzilli, Eva Havrdová et al. · Neurology · 2022 · 18 citations · Full text

Rows per page

1–3 of 3